IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rhenman & Partners Asset Management AB

Q3 2025 Holdings

Filed 2025-11-13 | 92 holdings | $903.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Boston Scientific Corp(BSX)COM101137107$42.8M438,0004.7%
Lilly ELI & Co(LLY)COM532457108$40.8M53,4204.5%
Abbvie Inc(ABBV)COM00287Y109$30.2M130,3753.3%
Danaher Corporation(DHR)COM235851102$26.7M134,4522.9%
Alignment Healthcare Inc(ALHC)COM01625V104$25.8M1,479,2842.9%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$21.7M48,5002.4%
United Health Group Inc(UNH)COM91324P102$21.6M62,5302.4%
Axsome Therapeutics Inc(AXSM)COM05464T104$21.0M172,8002.3%
CVS Health Corp(CVS)COM126650100$20.9M277,3622.3%
Mckesson Corp(MCK)COM58155Q103$20.5M26,6002.3%
Regeneron Pharmaceuticals(REGN)COM75886F107$20.3M36,1002.2%
Ionis Pharmaceuticals Inc(IONS)COM462222100$20.3M310,0002.2%
Medtronic PLC(MDT)SHSG5960L103$19.5M205,0002.2%
Cencora Inc(COR)COM03073E105$19.5M62,3752.2%
Exact Sciences Corp(EXAS)COM30063P105$19.0M348,0002.1%
Insmed Inc(INSM)COM PAR $.01457669307$19.0M131,8852.1%
Glaukos Corp(GKOS)COM377322102$18.8M230,0002.1%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$18.4M46,9552.0%
Insulet Corp(PODD)COM45784P101$17.9M58,0002.0%
Cooper COS Inc(COO)COM216648501$16.2M237,0001.8%
Neurocrine Biosciences Inc(NBIX)COM64125C109$16.1M114,7171.8%
Encompass Health Corp(EHC)COM29261A100$15.2M119,4001.7%
Cardinal Health Inc(CAH)COM14149Y108$14.8M94,0001.6%
Thermo Fisher Scientific Inc(TMO)COM883556102$14.6M30,0401.6%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$14.5M31,8751.6%
Cytokinetics Inc(CYTK)COM NEW23282W605$14.0M255,2501.6%
Procept Biorobotics Corp(PRCT)COM74276L105$13.9M390,0001.5%
The Cigna Group(CI)COM125523100$13.4M46,5001.5%
Abbott Labs(ABT)COM002824100$13.2M98,5001.5%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$12.5M95,0301.4%
Edwards Lifesciences Corp(EW)COM28176E108$12.1M155,0001.3%
Tenet Healthcare Corp(THC)COM NEW88033G407$11.9M58,4291.3%
Akero Therapeutics Inc(AKRO)COM00973Y108$10.9M230,6001.2%
Align Technology Inc(ALGN)COM016255101$10.4M83,0001.2%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$10.1M186,6501.1%
Doximity Inc(DOCS)CL A26622P107$9.9M136,0001.1%
Royalty Pharma PLC(RPRX)SHS CLASS AG7709Q104$9.1M258,5001.0%
Gilead Sciences Inc(GILD)COM375558103$8.9M80,1501.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$8.8M574,0001.0%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$8.4M18,2500.9%
Biogen Inc(BIIB)COM09062X103$7.7M55,0000.9%
Dynavax Technologies Corp(DVAX)COM NEW268158201$7.7M772,0000.8%
Adaptive Biotechnologies COR(ADPT)COM00650F109$7.4M495,0000.8%
Elevance Health Inc(ELV)COM036752103$7.3M22,5000.8%
Dianthus Therapeutics Inc(DNTH)COM252828108$6.8M173,6270.8%
Mineralys Therapeutics Inc(MLYS)COM603170101$6.3M165,0000.7%
Centene Corp del(CNC)COM15135B101$6.1M170,0000.7%
Stoke Therapeutics Inc(STOK)COM86150R107$5.9M250,0000.7%
Viking Therapeutics Inc(VKTX)COM92686J106$5.7M216,2880.6%
Anteris Technologies Global(AVR)COM03675P102$5.6M1,250,7630.6%
Page 1 of 2Next